Vankomisine Dirençli Enterokoklar (VRE) - EKMUD
Vankomisine Dirençli Enterokoklar (VRE) - EKMUD
Vankomisine Dirençli Enterokoklar (VRE) - EKMUD
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
11. Borroto-Esoda K, Arterburn S, Snow A, et al. Final analysis<br />
of virological outcomes and resistance during 5 years<br />
of adefovir dipivoxil monotherapy in HBeAg-negative<br />
patients (abstr). J Hepatol 2006;44(Suppl 2):179-80.<br />
12. Tenney DJ, Rose RE, Baldick CJ, et al. Two-year assessment<br />
of entecavir resistance in lamivudine-refractory hepatitis<br />
B virus patients reveals different clinical outcomes<br />
depending on the resistance substitutions present. Antimicrob<br />
Agents Chemother 2007;51:902-11.<br />
Reşat Özaras<br />
13. Colonno RJ, Rose RE, Pokornowski K, et al. Four year assessment<br />
of ETV resistance in nucleoside-naïve and lamivudine<br />
refractory patients (abstr). J Hepatol<br />
2007;46(Suppl 1):294.<br />
14. Pastor R, Habersetzer F, Fafi-Kremer S, et al. Hepatitis B<br />
virus mutations potentially conferring adefovir/tenofovir<br />
resistance in treatment-naive patients. World J Gastroenterol<br />
2009;15:753-5.<br />
2. TÜRKİYE <strong>EKMUD</strong> Bilimsel Platformu 2009 95
Change language